Certain aryl fused pyrrolopyrimidines; a new class of GABA brain receptor ligands
AssigneeNeurogen Corporation
InventorsAndrew Thurkauf, Alan Hutchison
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeurogen Corporation
InventorsAndrew Thurkauf, Alan Hutchison
Estimating the term…
The present invention encompasses structures of the formula: ##STR1## and the pharmaceutically acceptable non-toxic salts thereof wherein: ##STR2## and X represents hydrogen, halogen, or hydroxy; W represents an aryl group unsubstituted or substituted with various organic and inorganic substituents; A, B, C, D, and E represent carbon or nitrogen substituted with hydrogen or various organic and inorganic substituents; and R.sub.3, and R.sub.4 are variables representing various organic and inorganic substituents.. These compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs thereof and are useful in the diagnosis and treatment of anxiety, sleep, and seizure disorders, overdose with benzodiazepine drugs, and enhancement of memory.
A compound of the formula:
A compound of the formula:
A compound of the formula:
Dependencies are inferred from the claim text.